Diabetes, Nutrition and endocrinological diseases

Eduard Montanya Mias

PRINCIPAL INVESTIGATORS
  • Montserrat Nacher Garcia
  • Elisabet Estil·Les Altimiras
  • Lydia Escolano Soriano
  • Nuria Vilarrasa García
  • Nuria Virgili Casas
  • Manuel Pérez Maraver
  • Patricia San José Terrón
CLINICAL RESEARCHERS
  • Jorge Caballero Corchuelo
  • Laura Hernández Montoliu
  • Fernando Guerrero Pérez
  • Rafael López Urdiales
POSTDOCTORAL RESEARCHERS
  • Claudia Fernandez Alegre
PREDOCTORAL RESEARCHERS
  • Daniel Soriano Medrano
  • Kevin Andrés Rivera Loor
SCIENTIFIC SUPPORT
  • Maria Ferrés Prat
  • Marta Campos Gil
  • Esther Obea Gómez
MANAGEMENT SUPPORT
  • Maria Isabel Ramis Juan
Translational Medicine
Diabetes and Metabolism

Scientific production

26

PAPERS

Average IF: 5,467

11

LED PAPER

Average IF: 5,21

5 PUBLICATIONS IN FIRST DECILE

12 PUBLICATIONS IN FIRST QUARTILE

16 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Villanueva Carmona,T;Cedo,L;Madeira,A;Ceperuelo Mallafre,V;Rodriguez Pena,MM;Nunez Roa,C;Maymo Masip,E et al, SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression, Cell Metab., 2023;35(4):doi:10.1016/j.cmet.2023.03.004
  • Guerrero Pérez,F;Vilarrasa,N;Huánuco,LV;Busquets,J;Secanella,L;Vercher Conejero,JL;Vidal,N et al, Ectopic insulinoma: a systematic review, Rev. Endocr. Metab. Disord., 2023;24(6):1135-1146, doi:10.1007/s11154-023-09824-2
  • Montero,E;Bujaldón,R;Montanya,E;Calle Pascual,AL;Rojo Martínez,G;Castaño,L;Franch Nadal,J et al, Cross-sectional association between severe periodontitis and diabetes mellitus: A nation-wide cohort study, J. Clin. Periodontol., 2023;51(4):368-379, doi:10.1111/jcpe.13937
  • Rosenstock,J;Cariou,B;Eliasson,J;Frappin,G;Kaltoft,MS;Montanya,E;Knop,FK, Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studies, Diabetes Obes. Metab., 2023;26(2):532-539, doi:10.1111/dom.15339
  • Meier,JJ;Bardtrum,L;Cheng,A;Malling,B;Montanya,E;Wagner,L;Pratley,RE, Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis, Diabetes Obes. Metab., 2023;25(4):1130-1135, doi:10.1111/dom.14957

Research highlights

PROJECTS

4 Ongoing competitive projects

6 Ongoing clinical trials

PUBLISHED WORKS

2 Clinical Guidelines
1 Thesis

NETWORKS

CIBERDEM
AGAUR SGR GRC

Selected projects

  • 20FIS020. Role of ß-cell dedifferentiation in human islets failure and contribution of endoplasmic reticulum stress and mitochondrial dysfunction. Instituto de Salud Carlos III (ISCIII). Budget: 288.282,5€. 2020-2024. PI: Montanya Mias, Eduard.
  • FIS22048. Factores pronósticos y predictores de remisión de diabetes en técnicas de cirugía bariátrica hipoabsortivas: Estudio aleatorizado comparando Cruce Duodenal, SADI-S y Minigastric Bypass. Instituto de Salud Carlos III (ISCIII). Budget: 251.680€. 2023-2025. PI: Vilarrasa García, Nuria.
  • FIS22029. Plasticidad de la masa celular beta en la obesidad y la diabetes tipo 2: papel de las células ductales pancreáticas. Instituto de Salud Carlos III (ISCIII). Budget: 147.620€. 2023-2025. PI: Montanya Mias, Eduard.
  • INT21020. Comprehensive characterization of human ductal epithelium to identify endogenous progenitors as beta cell source. EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD). Budget: 50.448€. 2022-2024. PI: Montanya Mias, Eduard; Rovira Clusellas, Meritxell.
  • 19ACL090. Efectos de semaglutida a largo plazo en la retinopatía diabetica en sujectos con diabetes tipo 2 (FOCUS). Novartis Farmacéutica, S.A.;Novo Nordisk A/S;Novo Nordisk Pharma. Budget: 96.296€. 2019- . PI: Montanya Mias, Eduard.